实用肝脏病杂志 ›› 2018, Vol. 21 ›› Issue (6): 955-958.doi: 10.3969/j.issn.1672-5069.2018.06.031

• 肝癌 • 上一篇    下一篇

微波消融联合经肝动脉介入栓塞化疗和全身化疗治疗结直肠癌肝转移患者临床疗效比较*

叶璇, 张鹏   

  1. 430005武汉市 华中科技大学同济医学院附属同济医院胃肠外科
  • 收稿日期:2018-03-30 出版日期:2018-11-10 发布日期:2018-12-25
  • 作者简介:叶璇,女,35岁,大学本科。E-mail:1570882128@qq.com
  • 基金资助:
    *湖北省自然科学基金资助项目(编号:7887392)

Efficacy of microwave ablation combined with transcatheter arterial chemoembolization in treatment of patients with hepatic metastasis from colorectal cancer

Ye Xuan, Zhang Peng.   

  1. Department of Gastrointestinal Surgery,Tongji Hospital,Tongji Medical School Huazhong University of Science and Technology,Wuhan 430005,Hubei Province,China
  • Received:2018-03-30 Online:2018-11-10 Published:2018-12-25

摘要: 目的 探讨采用微波消融联合经肝动脉栓塞化疗(TACE)治疗结直肠癌肝转移患者的临床疗效。方法 2012年6月~2015年6月我院收治的90例结直肠癌肝转移患者,45例对照组接受全身化疗治疗,而另45例观察组接受TACE联合微波消融治疗。比较两组患者应答情况及外周血淋巴细胞亚群的变化情况。结果 在治疗6个月末,观察组完全缓解(CR)、部分缓解(PR)、疾病稳定(SD)和疾病进展(PD)率分别为28.9%、40.0%、20.0%和11.1%,显著优于对照组的11.1%、28.9%、26.7%和33.3%(x2=7.571,P=0.006);治疗前,两组患者外周血CD8+、CD4+和CD3+细胞百分比及CD4+/CD8+细胞比值比较,差异无统计学意义(P>0.05),而在治疗后,观察组外周血CD3+和CD4+细胞百分比及CD4+/CD8+细胞比值改善情况显著优于对照组(t=7.256、t=5.916、t=7.701,P<0.01);随访发现,对照组患者平均生存时间为(16.0±5.2)个月,显著短于观察组的(29.1±8.4)个月(t=8.895,P<0.001)。结论 采用微波消融术联合TACE治疗结直肠癌肝转移患者临床有效,能有效改善患者的免疫功能,延长生存期。

关键词: 肝转移癌, 结直肠癌, 微波消融术, 经肝动脉栓塞化疗, 临床疗效

Abstract: Objective To investigate the efficacy of microwave ablation combined with transcatheter arterial chemoembolization(TACE) in treatment of patients with hepatic metastasis from colorectal cancer. Methods 90 patients with liver metastasis who had colorectal cancer removed were recruited in our hospital between June 2012 and June 2015,and were divided into control group receiving systemic chemotherapy (n=45) and observation group receiving microwave ablation combined with TACE (n=45). Comparison of the therapeutic efficacy,prognosis and changes of peripheral blood lymphocyte subsets between the two groups was made. Results At the end of 6 month followed-up,the complete response,partial response,stable disease and progress of disease in the combination group were 28.9%,40.0%,20.0% and 11.1%,significantly superior to 11.1%,28.9%,26.7% and 33.3% (x2=7.571,P=0.006) in the control group;at presentation,the percentages of peripheral blood CD8+ cells,CD4+ cells and CD3+ cells as well as the ratio of CD4+/CD8+ cells in two groups were not significantly different(P>0.05),while at the end of three month treatment,the percentages of peripheral blood CD8+ cells,CD4+ cells and CD3+ cells as well as the ratio of CD4+/CD8+ cells in the combination group improved obviously as compared to those in the control(t=7.256,t=5.916,t=7.701,t=7.013,P<0.01);the follow-up demonstrated that the survival time in the control group was (16.0±5.2) m,significantly shorter than (29.1±8.4) m(t=8.895,P<0.001) in the combination group. Conclusion The application of microwave ablation and interventional embolization chemotherapy in the treatment of patients with liver metastasis from colorectal cancer has to some intent clinical good efficacy,which might effectively improve the immune function of patients and prolong the patient's survival.

Key words: Colorectal liver metastases, Microwave ablation, Transcatheter arterial chemoembolization, Clinical efficacy